R
Re-Cognition Health | Guildford, United Kingdom
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
LY3314814
Lanabecestat
Lasmiditan
LY573144
JNJ-64042056
Parent organization
This site is a part of Re-Cognition Health
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 5 total trials
The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease Cognitive Comp...
Enrolling
Preclinical Alzheimer's Disease
Drug: JNJ-64042056
Drug: Placebo
The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatmen...
Active, not recruiting
Migraine
Drug: Placebo comparator dosing
Drug: Rimegepant 75mg every other day dosing
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems